Hillsborough, NJ, United States of America

Nicole Risher

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., Ptc Therapeutics, Inc.. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicole Risher: Innovator in Spinal Muscular Atrophy Treatment

Introduction

Nicole Risher is a prominent inventor based in Hillsborough, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of spinal muscular atrophy. Her innovative work has led to the development of a patent that addresses this critical health issue.

Latest Patents

Nicole Risher holds a patent for "Compounds for treating spinal muscular atrophy." The present invention provides compounds of formula (I) wherein A, B, X, Y, R1, and R2 are as described herein, as well as pharmaceutically acceptable salts thereof. Furthermore, the invention is concerned with the manufacture of these compounds, pharmaceutical compositions comprising them, and their use as medicaments.

Career Highlights

Throughout her career, Nicole has worked with notable companies such as Hoffmann-La Roche Inc. and PTC Therapeutics, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Nicole has collaborated with talented individuals, including Amal Dakka and Luke Green. These partnerships have fostered an environment of innovation and creativity, leading to advancements in her research.

Conclusion

Nicole Risher's work in developing compounds for treating spinal muscular atrophy showcases her dedication to improving healthcare through innovation. Her contributions are vital in the ongoing fight against this debilitating condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…